Company Reports Q4 Revenue of $15.17M, Beating Expectations
Reports Q4 revenue $15.17M, consensus $14.12M. "During the fourth quarter, we continued to advance the strategies underlying Joint 2.0, the first phase of our transformation journey," said President and CEO, Sanjiv Razdan. "These strategies, which were introduced a year ago, remain on track to be fully executed by the end of this year. Our execution to date is highlighted by our progress towards becoming a pure-play franchisor, as we have refranchised 41 and are in the process of refranchising 27 previously company-owned clinics since the beginning of 2025, which will leave us with just 48 clinics that remain company-owned and for which we continue to make progress with refranchising efforts. As we near completion of this transition, we also continue to implement operational discipline to drive improved operating leverage, which is reflected in the year over year Adjusted EBITDA improvements in the 2025 fourth quarter and full year periods despite certain macro-economic headwinds that challenged comp sales and overall revenue performance."
Trade with 70% Backtested Accuracy
Analyst Views on JYNT
About JYNT
About the author

- New Executive Appointment: Michelle Reap has been appointed as the Director of Franchise Development at The Joint Corp., leveraging over 20 years of franchise industry experience to drive strategic growth by connecting the brand with qualified partners for national expansion.
- Rich Industry Background: Reap has held leadership roles at renowned brands such as Yum! Brands and la Madeleine Bakery & Café, with expertise in new development, growth expansion, and remodel initiatives, which will significantly bolster The Joint's ongoing development efforts.
- Alignment with Brand Mission: CEO Sanjiv Razdan emphasized that Reap's addition will help the company find the right people to carry forward the brand's mission, ensuring that sustainable growth is rooted in a patient-first model based on quality chiropractic care.
- Market Leadership Position: With over 950 clinics across 43 states and more than 14 million patient visits annually, The Joint's no-insurance, affordable membership plans have established it as a trusted name in the health and wellness franchise sector, further solidifying its market leadership.
- New Executive Appointment: Michelle Reap has been appointed as the Director of Franchise Development at The Joint Corp., bringing over 20 years of franchise industry experience to drive strategic growth by connecting the brand with qualified partners for national expansion.
- Rich Industry Background: Reap has held leadership roles at renowned brands like Yum! Brands and la Madeleine Bakery & Café, with expertise in new development, growth expansion, and remodel initiatives, which will invigorate The Joint's development efforts.
- Patient-First Model: With over 950 clinics across 43 states, The Joint employs a no-insurance, affordable membership plan aimed at delivering quality chiropractic care, establishing itself as a trusted name in the health and wellness franchise sector.
- Sustainable Growth Strategy: CEO Sanjiv Razdan emphasizes that Reap's addition will enhance the company's success in finding the right partners to carry forward the brand's mission, ensuring sustainable growth in the competitive market.
- Enhanced Employee Wellness: Miller Subaru's new agreement with The Joint provides approximately 275 employees access to chiropractic care at preferred pricing in Utah, reflecting the company's commitment to employee health.
- Convenient No-Appointment Care: This partnership allows employees to receive chiropractic treatment without appointments, facilitating easier access to care that can improve overall health and workplace productivity.
- Market Expansion Strategy: The collaboration not only offers health benefits to Miller Subaru employees but also drives patient traffic to The Joint's franchise clinics in Utah, supporting long-term success and market share growth.
- Corporate Responsibility: Miller Subaru's investment in health benefits demonstrates its commitment to employee well-being, aiming to enhance quality of life through affordable health services and inspiring other employers to consider similar partnerships.
- Enhanced Employee Wellness: Miller Subaru's partnership with The Joint provides approximately 275 employees access to discounted chiropractic care at The Joint's Utah clinics, reflecting the company's commitment to employee health.
- Convenient No-Appointment Care: This collaboration allows employees to receive chiropractic treatment without appointments, promoting health awareness and potentially increasing workplace productivity through accessible care.
- Market Expansion Strategy: The partnership not only offers health benefits to Miller Subaru employees but also drives patient traffic to The Joint's franchise clinics in Utah, supporting long-term success and growth in market share.
- Investment in Health Philosophy: Miller Subaru's investment in health benefits underscores its belief that employees are its greatest asset, aiming to enhance quality of life and job satisfaction through easily accessible health services.
- Transformation Progress: CEO Sanjiv Razdan emphasized that the company is on track to complete its shift to a pure-play franchise model by the end of 2026, with only 48 corporate-owned clinics remaining from 135, which is expected to enhance operational efficiency and market competitiveness.
- Financial Performance: CFO Scott Bowman reported that system-wide sales for 2025 were flat at $532 million, while adjusted EBITDA grew by 13.9% to $13 million, reflecting positive effects from cost optimization despite overall sales stagnation.
- Marketing Adjustments: The company has shifted its marketing focus from broad wellness messaging to chiropractic care for pain relief, with a new national media program launched in November showing early signs of improvement in patient acquisition, although still below last year's levels.
- Future Outlook: The company projects system-wide sales for 2026 to range between $519 million and $552 million, and despite challenges with new patient attrition, management remains optimistic about long-term growth potential, believing the U.S. market could support over 1,800 clinics.










